Search Results - Alessandro Cellini
- Showing 1 - 19 results of 19
-
1
-
2
-
3
Case Report: Triplet combination with pirtobrutinib/venetoclax/rituximab in accelerated phase of chronic lymphocytic leukemia by Andrea Serafin, Alessandro Cellini, Francesco Angotzi, Valeria Ruocco, Arianna Bevilacqua, Marco Pizzi, Livio Trentin, Andrea Visentin
Published in Frontiers in Hematology (2025-03-01)Get full text
Article -
4
A Case of Hemophagocytic Lymphohistiocytosis Triggered by Disseminated Tuberculosis and Hairy Cell Leukaemia after SARS-CoV2 Infection by Alessandro Cellini, Andrea Visentin, Massimiliano Arangio Febbo, Susanna Vedovato, Serena Marinello, Ivo Tiberio, Livio Trentin, Carmela Gurrieri
Published in Applied Sciences (2022-01-01)Get full text
Article -
5
Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells by Alessandro Cellini, Federico Scarmozzino, Francesco Angotzi, Edoardo Ruggeri, Angelo Paolo Dei Tos, Livio Trentin, Marco Pizzi, Andrea Visentin
Published in Frontiers in Oncology (2023-05-01)Get full text
Article -
6
Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases by Francesco Angotzi, Andrea Visentin, Federico Scarmozzino, Alessandro Cellini, Roberta Bertorelle, Marco Pizzi, Gianni Binotto, Angelo Paolo Dei Tos, Livio Trentin
Published in Current Oncology (2022-02-01)Get full text
Article -
7
Right atrial thrombus in treatment-naive patient with an early-stage classical Hodgkin lymphoma: a case report and review of the literature by Anna Giordano, Valentina Bodanza, Francesco Angotzi, Alessandro Cellini, Arianna Bevilacqua, Mattia D’Antiga, Martina De Ferrari, Valeria Pergola, Elena Campello, Livio Trentin, Andrea Visentin
Published in Frontiers in Hematology (2026-06-01)Get full text
Article -
8
Outcomes of patients with CLL and borderline IGHV mutational status: a systematic review and meta analysis by Francesco Angotzi, Arianna Bevilacqua, Andrea Serafin, Nicolò Danesin, Alessandro Cellini, Giovanni Leone, Mattia D’Antiga, Elisa Pagnin, Federica Frezzato, Monica Facco, Francesco Piazza, Livio Trentin, Andrea Visentin
Published in Biomarker Research (2026-04-01)Get full text
Article -
9
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Def... by Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavaretta, Valeria Ruocco, Silvia Imbergamo, Francesco Piazza, Giulia Proietti, Francesca Romana Mauro, Livio Trentin
Published in Current Oncology (2022-12-01)Get full text
Article -
10
P054: The Kinase CK2 is deregulated and targetable in classical Hodgkin Lymphoma by Andrea Visentin, Edoardo Ruggeri, Federica Frezzato, Marco Pizzi, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavarretta, Valeria Ruocco, Stefano Pravato, Filippo Severin, Monica Facco, Sabrina Manni, Francesci Piazza, Livio Trentin
Published in HemaSphere (2022-10-01)Get full text
Article -
11
Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD by Alessandro Cellini, Chiara Adele Cavarretta, Francesco Angotzi, Valeria Ruocco, Andrea Serafin, Nicolò Danesin, Marco Pizzi, Michele Gregianin, Stefania Vio, Filippo Crimì, Federica Vianello, Francesco Piazza, Livio Trentin, Andrea Visentin
Published in Frontiers in Oncology (2024-09-01)Get full text
Article -
12
P1075: ADVANCED-STAGE CHL INTERNATIONAL PROGNOSTICATION INDEX: EXTERNAL VALIDATION IN A SINGLE-CENTER RETROSPECTIVE PATIENT DATASET AND COMPARISON TO THE HASENCLEVER IPS by Alessandro Cellini, Chiara Adele Cavarretta, Francesco Angotzi, Valeria Ruocco, Andrea Serafin, Ivan Zatta, Michele Gregianin, Stefania Vio, Filippo Crimì, Federica Vianello, Marco Pizzi, Stefano Pravato, Livio Trentin, Andrea Visentin
Published in HemaSphere (2023-08-01)Get full text
Article -
13
P005: Age, histotype and stage IV are associated with a shorter survival in patients with Hodgkin lymphoma, even the PET-adapted era. A single center retrospective study. by Andrea Visentin, Alessandro Cellini, Chiara Adele Cavarretta, Leila Romano Gargarella, Francesco Angotzi, Valeria Ruocco, Simone Zoletto, Stefano Pravato, Marco Pizzi, Federica Vianello, Filippo Crimì, Stefania Vio, Michele Gregianin, Livio Trentin
Published in HemaSphere (2022-10-01)Get full text
Article -
14
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy by Edoardo Ruggeri, Federica Frezzato, Nayla Mouawad, Marco Pizzi, Federico Scarmozzino, Guido Capasso, Valentina Trimarco, Laura Quotti Tubi, Alessandro Cellini, Chiara Adele Cavarretta, Valeria Ruocco, Andrea Serafin, Francesco Angotzi, Nicolò Danesin, Sabrina Manni, Monica Facco, Francesco Piazza, Livio Trentin, Andrea Visentin
Published in Frontiers in Immunology (2024-05-01)Get full text
Article -
15
Predicting thrombotic risk in patients with classical Hodgkin lymphoma: Thro‐HL multicenter study by Giovanni Manfredi Assanto, Eleonora Alma, Alessandro Cellini, Giovanni Marsili, Gianluca Maiorana, Cristina Santoro, Martina Salvatori, Natalia Cenfra, Vladimir Otasevic, Darko Antic, Gianna Maria D'Elia, Maria Paola Bianchi, Giorgia Annechini, Silvio Ligia, Alessandro Pulsoni, Agostino Tafuri, Andrea Visentin, Alfonso Piciocchi, Stefan Hohaus, Maurizio Martelli, Ilaria Del Giudice, Antonio Chistolini
Published in HemaSphere (2025-07-01)Get full text
Article -
16
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies by Francesco Angotzi, Marco Petrella, Tamara Berno, Gianni Binotto, Giorgia Bonetto, Antonio Branca, Marco Carraro, Chiara Adele Cavaretta, Alessandro Cellini, Fabio D’Amore, Laura Forlani, Ilaria Gianesello, Carmela Gurrieri, Silvia Imbergamo, Federica Lessi, Antonio Maroccia, Federica Mazzetto, Laura Pavan, Sara Pezone, Francesco Piazza, Stefano Pravato, Valeria Ruocco, Greta Scapinello, Fabrizio Vianello, Renato Zambello, Ivan Zatta, Simone Zoletto, Andrea Padoan, Livio Trentin, Andrea Visentin
Published in Frontiers in Oncology (2023-06-01)Get full text
Article -
17
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study by Andrea Visentin, Andrea Visentin, Francesca Romana Mauro, Gioachino Catania, Alberto Fresa, Candida Vitale, Alessandro Sanna, Veronica Mattiello, Francesca Cibien, Paolo Sportoletti, Massimo Gentile, Gian Matteo Rigolin, Francesca Maria Quaglia, Roberta Murru, Alessandro Gozzetti, Stefano Molica, Monia Marchetti, Stefano Pravato, Francesco Angotzi, Alessandro Cellini, Lydia Scarfò, Gianluigi Reda, Marta Coscia, Luca Laurenti, Paolo Ghia, Robin Foà, Antonio Cuneo, Livio Trentin, Livio Trentin
Published in Frontiers in Oncology (2022-11-01)Get full text
Article -
18
Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort by Andrea Serafin, Alessandro Cellini, Enrica Antonia Martino, Federica Mazzetto, Francesco Angotzi, Anna Maria Frustaci, Monia Marchetti, Riccardo Moia, Alessandro Sanna, Costantino Riemma, Francesca Cibien, Alessandro Noto, Enrico Lista, Myriam Foglietta, Candida Vitale, Vanessa Innao, Martina Bullo, Ester Lovato, Isacco Ferrarini, Costanza Andriola, Laura Ballotta, Idanna Innocenti, Alberto Fresa, Gianmarco Favrin, Marzia Varettoni, Elisa Santambrogio, Lorella Orsucci, Raffaella Pasquale, Massimo Moratti, Luca Laurenti, Marta Coscia, Paolo Sportoletti, Roberto Marasca, Francesca Romana Mauro, Caterina Patti, Enrico Derenzini, Lydia Scarfò, Paolo Ghia, Antonio Cuneo, Alessandra Tedeschi, Livio Trentin, Massimo Gentile, Andrea Visentin
Published in Blood Advances (2025-07-01)Get full text
Article -
19
Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study by Eleonora Roncaglia, Enrico Gaffo, Giulia Calabretto, Moritz Fürstenau, Kerry A. Rogers, Panagiotis Baliakas, Chenghua Cui, Cecelia Miller, Claudia Haferlach, Karla Plevova, David Oscier, Zadie Davis, Florence Nguyen-Khac, Gian Matteo Rigolin, Anastasia Athanasiadou, Fanny Baran-Marszak, Alberto Valiente, Maria José Terol, Pau Abrisqueta, Blanca Espinet, Anna Puiggros, Annalisa Martines, Laura Bonaldi, Francesca Romana Mauro, Lydia Scarfò, Thomas Chatzikonstantinou, Eugen Tausch, Karl-Anton Kreuzer, Arnon Kater, Francesc Bosch, Michael Doubek, Panagiotis Panagiotidis, Olga Kalashnikova, Federica Frezzato, Valeria Ruocco, Silvia Orsi, Kimia Salek, Roberto Merlo, Alberto Caregari, Ilias Glogovitis, Alessandro Cellini, Francesco Angotzi, Andrea Serafin, Shuhua Yi, Barbara Eichhorst, Jennifer A. Woyach, Antonio Cuneo, Paolo Ghia, Kostas Stamatopoulos, Livio Trentin, Andrea Visentin, Stefania Bortoluzzi
Published in Journal of Hematology & Oncology (2025-07-01)Get full text
Article